Detalhe da pesquisa
1.
A prospective cohort study identifies two types of HIV+ Kaposi Sarcoma lesions: proliferative and inflammatory.
Int J Cancer
; 153(12): 2082-2092, 2023 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37602960
2.
A Banff-based histologic chronicity index is associated with graft loss in patients with a kidney transplant and antibody-mediated rejection.
Kidney Int
; 103(1): 187-195, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36332728
3.
Clazakizumab for desensitization in highly sensitized patients awaiting transplantation.
Am J Transplant
; 22(4): 1133-1144, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34910841
4.
Assessment of humoral and cellular immune responses to SARS CoV-2 vaccination (BNT162b2) in immunocompromised renal allograft recipients.
Transpl Infect Dis
; 24(2): e13813, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35202497
5.
The role of novel therapeutic approaches for prevention of allosensitization and antibody-mediated rejection.
Am J Transplant
; 20 Suppl 4: 42-56, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32538536
6.
IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation.
N Engl J Med
; 377(5): 442-453, 2017 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28767349
7.
Early clinical experience using donor-derived cell-free DNA to detect rejection in kidney transplant recipients.
Am J Transplant
; 19(6): 1663-1670, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30725531
8.
Allocation of the Highest Quality Kidneys and Transplant Outcomes Under the New Kidney Allocation System.
Am J Kidney Dis
; 73(5): 605-614, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30929853
9.
A phase I/II, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipients.
Am J Transplant
; 18(12): 2955-2964, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29637714
10.
Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies.
Kidney Int
; 91(3): 729-737, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28104301
11.
Six-year outcomes in broadly HLA-sensitized living donor transplant recipients desensitized with intravenous immunoglobulin and rituximab.
Transpl Int
; 29(12): 1276-1285, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27529314
12.
Risk factors associated with the development of histocompatibility leukocyte antigen sensitization.
Curr Opin Organ Transplant
; 21(4): 447-52, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27258577
13.
Histopathologic features of transplant glomerulopathy associated with response to therapy with intravenous immune globulin and rituximab.
Clin Transplant
; 28(5): 546-53, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24579925
14.
Design of a protease-activated PD-L1 inhibitor.
Protein Sci
; 32(3): e4578, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36705186
15.
An Assessment of the Value of Donor-derived Cell-free DNA Surveillance in Patients With Preserved Kidney Allograft Function.
Transplantation
; 107(1): 274-282, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35913057
16.
Large-scale heparin-based bind-and-elute chromatography identifies two biologically distinct populations of extracellular vesicles.
J Extracell Vesicles
; 12(6): e12327, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37272197
17.
Pediatric HIV+ Kaposi sarcoma exhibits clinical, virological, and molecular features different from the adult disease.
JCI Insight
; 8(22)2023 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37991023
18.
Evaluation of Clazakizumab (Anti-Interleukin-6) in Patients With Treatment-Resistant Chronic Active Antibody-Mediated Rejection of Kidney Allografts.
Kidney Int Rep
; 7(4): 720-731, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35497778
19.
Rituximab and intravenous immune globulin for desensitization during renal transplantation.
N Engl J Med
; 359(3): 242-51, 2008 Jul 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-18635429
20.
Infectious Complications in Tocilizumab-treated Kidney Transplant Recipients.
Transplantation
; 105(8): 1818-1824, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33534530